Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
What is your diagnosis?
Nohuz E, Albaut M, Kullab S, Fattouh M, Tamburro S, Dauplat MM, Benoît C, Durando X. Nohuz E, et al. Among authors: kullab s. J Turk Ger Gynecol Assoc. 2014 Dec 1;15(4):262-3. doi: 10.5152/jtgga.2014.14189. eCollection 2014. J Turk Ger Gynecol Assoc. 2014. PMID: 25584039 Free PMC article. No abstract available.
Vaginal Lymphoma: A Possible Cause of Genital Hemorrhage.
Nohuz E, Kullab S, Ledoux-Pilon A, Moluçon-Chabrot C, Albaut M, De Simone L, Durando X. Nohuz E, et al. Among authors: kullab s. Turk J Haematol. 2016 Sep 5;33(3):259-60. doi: 10.4274/tjh.2015.0112. Epub 2016 Apr 18. Turk J Haematol. 2016. PMID: 27094853 Free PMC article. No abstract available.
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.
Nabholtz JM, Chalabi N, Radosevic-Robin N, Dauplat MM, Mouret-Reynier MA, Van Praagh I, Servent V, Jacquin JP, Benmammar KE, Kullab S, Bahadoor MR, Kwiatkowski F, Cayre A, Abrial C, Durando X, Bignon YJ, Chollet P, Penault-Llorca F. Nabholtz JM, et al. Among authors: kullab s. Int J Cancer. 2016 May 1;138(9):2274-80. doi: 10.1002/ijc.29952. Epub 2015 Dec 28. Int J Cancer. 2016. PMID: 26649807 Clinical Trial.
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P, Penault-Llorca F, Nabholtz JM. Wang-Lopez Q, et al. Among authors: kullab s. Crit Rev Oncol Hematol. 2015 Jul;95(1):88-104. doi: 10.1016/j.critrevonc.2015.02.011. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25900915 Review.
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.
Nabholtz JM, Abrial C, Mouret-Reynier MA, Dauplat MM, Weber B, Gligorov J, Forest AM, Tredan O, Vanlemmens L, Petit T, Guiu S, Van Praagh I, Jouannaud C, Dubray-Longeras P, Tubiana-Mathieu N, Benmammar KE, Kullab S, Bahadoor MR, Radosevic-Robin N, Kwiatkowski F, Desrichard A, Cayre A, Uhrhammer N, Chalabi N, Chollet P, Penault-Llorca F. Nabholtz JM, et al. Among authors: kullab s. Ann Oncol. 2014 Aug;25(8):1570-7. doi: 10.1093/annonc/mdu183. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827135 Free article. Clinical Trial.
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.
AlSaleh K, Al Zahwahry H, Bounedjar A, Oukkal M, Saadeddine A, Mahfouf H, Bouzid K, Bensalem A, Filali T, Abdel-Razeq H, Larbaoui B, Kandil A, Abulkhair O, Al Foheidi M, Errihani H, Ghosn M, Abdel-Aziz N, Arafah M, Boussen H, Dabouz F, Rasool H, Bahadoor M, Ayari J, Kullab S, Nabholtz JM. AlSaleh K, et al. Among authors: kullab s. JCO Glob Oncol. 2021 Jun;7:811-819. doi: 10.1200/GO.20.00575. JCO Glob Oncol. 2021. PMID: 34086481 Free PMC article. Clinical Trial.
Breast-cancer detection using blood-based infrared molecular fingerprints.
Kepesidis KV, Bozic-Iven M, Huber M, Abdel-Aziz N, Kullab S, Abdelwarith A, Al Diab A, Al Ghamdi M, Hilal MA, Bahadoor MRK, Sharma A, Dabouz F, Arafah M, Azzeer AM, Krausz F, Alsaleh K, Zigman M, Nabholtz JM. Kepesidis KV, et al. Among authors: kullab s. BMC Cancer. 2021 Dec 2;21(1):1287. doi: 10.1186/s12885-021-09017-7. BMC Cancer. 2021. PMID: 34856945 Free PMC article.
[Primary digestive melanomas: is there any consensus?].
Eddekkaoui H, Guy JB, Falk AT, Lahmar R, Trone JC, Bahadoor MR, Kullab S, Collard O, Rivoirard R, Moriceau G, Vignot S, Magné N. Eddekkaoui H, et al. Among authors: kullab s. Bull Cancer. 2014 Jun;101(6):637-40. doi: 10.1684/bdc.2014.1948. Bull Cancer. 2014. PMID: 24977452 Review. French.
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study.
Selvy M, Pereira B, Kerckhove N, Gonneau C, Feydel G, Pétorin C, Vimal-Baguet A, Melnikov S, Kullab S, Hebbar M, Bouché O, Slimano F, Bourgeois V, Lebrun-Ly V, Thuillier F, Mazard T, Tavan D, Benmammar KE, Monange B, Ramdani M, Péré-Vergé D, Huet-Penz F, Bedjaoui A, Genty F, Leyronnas C, Busserolles J, Trevis S, Pinon V, Pezet D, Balayssac D. Selvy M, et al. Among authors: kullab s. J Clin Med. 2020 Jul 27;9(8):2400. doi: 10.3390/jcm9082400. J Clin Med. 2020. PMID: 32727095 Free PMC article.
22 results